Latest news
Maplight Therapeutics (NASDAQ:MPLT) Shares Down 6.4% - Time to Sell? - MarketBeatMarketBeat · Fri, 07 Aug 2026 16:50:32 GMTBronstein, Gewirtz & Grossman, LLC Is Investigating MapLight Therapeutics, Inc. (MPLT) And Encourages Investors to Connect - ACCESS NewswireACCESS Newswire · Fri, 07 Aug 2026 08:03:41 GMTMPLT Investors Have Opportunity to Join MapLight Therapeutics, Inc. Fraud Investigation with SBS Law - TradingViewTradingView · Mon, 03 Aug 2026 06:22:00 GMTMaplight Therapeutics, Inc. (NASDAQ:MPLT) Receives Average Recommendation of "Buy" from Analysts - MarketBeatMarketBeat · Thu, 30 Jul 2026 07:00:00 GMTADAR1 Capital Management LLC Purchases New Position in Maplight Therapeutics, Inc. $MPLT - MarketBeatMarketBeat · Wed, 29 Jul 2026 07:18:09 GMTTraders are paying attention to the gapping stocks in Wednesday's session. - ChartMillChartMill · Wed, 29 Jul 2026 07:00:00 GMTMaplight Therapeutics (NASDAQ:MPLT) Shares Up 18.2% Following Insider Buying Activity - MarketBeatMarketBeat · Wed, 29 Jul 2026 07:00:00 GMTA Quick Look at Today's Ratings for MapLight Therapeutics(MPLT.US), With a Forecast Between $21 to $45 - MoomooMoomoo · Tue, 28 Jul 2026 13:00:01 GMT